SLC18A2, the human vesicular monoamine transporter 2 gene, is associated with a number of brain disorders, including alcoholism, Parkinson's disease (PD), and schizophrenia (1) (2) (3) (4) (5) (6) . Molecular studies have revealed that the low activity-associated haplotypes are risk factors for these diseases. Consistently, one copy deletion of the gene increases both alcohol consumption and dopaminergic vulnerability in ϩ/Ϫ mice (7) (8) (9) , demonstrating the contribution of reduced SLC18A2 expression to alcoholism and PD. Interestingly, the SLC18A2 promoter has at least 20 haplotypes (A-T, where T is newly identified in this study), and one of them, designated A, had a frequency of 66.7% in 730 unrelated Caucasians from 2 independent collections. In vitro analyses showed that a medium level of promoter activity was displayed by A, whereas higher activity by C and lower activity by G were observed consistently in different cellular systems. Although highly selected, A was among the disease-associated haplotypes (3, 4) .
The vesicular monoamine transporter 2 (VMAT2) is an important molecule for the function of monoaminergic neurons that are key participants in locomotion, reward, working memory, and mnemonic brain systems. Acting to remove cytosolic monoamines [dopamine (DA), serotonin, norepinephrine, and histamine] by uptake into intracellular vesicles and to discharge the monoamines into extracellular space, VMAT2 prevents neurotoxicity of these monoamines in the cytosol and regulates neurotransmission (10) . VMAT2 is expressed in central, peripheral, and enteric neurons as well as in platelets (11, 12) . The expressional difference between different human brain regions can be Ͼ16-fold (13) . Data from knockout mice indicate that expression of VMAT2 is essential for survival and that different expression levels have altered behavioral consequences. Homozygous (Ϫ/Ϫ) knockout mice survive only about 1 postnatal week because of developmental defects, which is in contrast to other monoamine transporters, for which homozygous deletions (Ϫ/Ϫ) cause no lethality (14) . Nobably, environmental factors can regulate expression of the VMAT2 gene, including stress, clozapine, and environmental contaminants (15) (16) (17) . Despite the small number of regulation studies available, these data all suggest that the VMAT2 gene is under sensitive physiological regulation.
By investigating haplotype-dependent regulation of SLC18A2, in this study, we took a functional analysis approach to understanding why SLC18A2 promoter haplotype A is highly selected in the human lineage, whereas others are deselected. Elucidation of the biological drive for the selections may help our under-standing of the contributions of SLC18A2 to human evolution and diseases.
MATERIALS AND METHODS

Haplotype-reporter hybrid constructions
SLC18A2 promoter region-luc (fruit fly luciferase gene) hybrids were constructed by shuttling 8.5-kb NheI/BamHI fragments of plasmids pGL3e-hVMAT2-6.1A and pGL3e-hVMAT2-6.1C (3) into pGL4.14[luc2/Hygro] (Promega, Madison, WI, USA), resulting in 12.1-kb plasmids pSLC18A2-6.3A-luc and pSLC18A2-6.3C-luc. A 5.5-kb haplotype G or T fragment was cloned by PCR from a G or T carrier and after confirmation of PCR fidelity by DNA sequencing (Supplemental Fig. S1B ; Supplemental Table S1A , B) was shuttled into pSLC18A2-6.3A-luc, resulting in pSLC18A2-6.3G-luc or pSLC18A2-6.3T-luc. The control vector was generated by replacing the 2.0-kb NheI/HindIII fragment in pGL4.14[luc2/Hygro] with the 2.2-kb NheI/HindIII fragment of pGL3-Enhancer. To linearize the plasmids, NheI located immediately upstream of SLC18A2 DNA was used for restriction digestion (Supplemental Fig. S1A ), followed by purification with a QIAEX II Gel Extraction Kit (Qiagen, Valencia, CA, USA). Haplotype confirmation of SY-SY5Y genomic DNA for SLC18A2 used PCR and DNA resequencing primers listed in Supplemental  Table S1E .
Transfection, agent treatments, and luciferase activity measurements
The transfection procedure has been described before (3) . Eighteen-hour treatments of transfected cells with agents, as listed in Table 1 (VectorϪMOCK) , where MOCK means transfection without DNA, a background control.
Stable cell line establishment and immunocytochemistry
Establishment of stable cell lines followed a previous protocol (18) , using BstEII-linearized pSLC18A2-6.3A-luc (Supplemental Fig. S1A ) and cloning medium containing 100 g/ml hygromycin B (Invitrogen, Carlsbad, CA, USA) until colonies appeared, followed by Luc activity and immunocytochemical analyses (19) . Luc activity uses (readout/protein) (SLC18A2ϪMOCK) .
Electrophoretic mobility shift assay (EMSA)
For 35 S-labeling of oligonucleotides (oligos) (listed in Supplemental Table S1C ), double-stranded (ds) oligos were prepared in annealing buffer (10 mM Tris-HCl, pH 8.0, and 100 mM MgCl 2 ), and 20 M ds oligo was labeled in a 30-l solution containing 0.5 l of 20 M annealed ds oligos, 3 l of 10ϫ Reaction Buffer 2 (New England Biolabs, Ipswich, MA, USA), 6 l of [
35 S]dATP (60 pmol; PerkinElmer Life and Analytical Sciences, Waltham, MA, USA), and 1 l of Large Fragment DNA Polymerase I (Invitrogen), incubated at room temperature for 28 min followed by purification in a Chroma Spin-10 column (Clontech, Mountain View, CA, USA). DNA binding reactions were conducted with a Novagen EMSA Accessory Kit (EMD Biosciences, Gibbstown, NJ, USA), and electrophoresis was performed with 0.6% nondenaturing DNA retardation gels according to the EMSA kit instructions. Gels were dried on filter papers and exposed to X-ray film for 3-5 d for autoradiography.
Quantitation of mRNA levels by quantitative real-time PCR (qRT-PCR)
Reverse transcription was performed with Superscript II reverse transcriptase (Qiagen) oligo(dT) as the primer. Quantitative PCR reactions was conducted with SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and primers listed in Supplemental Table S1D . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ␤-actin were used as internal controls. Relative expression levels were calculated by using the 2 Ϫ⌬⌬CT method (20) . SLC18A2 primers showed amplification efficiency approximately equal (within 5% difference) to that of the internal controls.
Southern blotting
Biotin labeling of a probe (1.1-kb AvaI/HindIII fragment within the luc gene) was performed with the BrightStar Psoralen-Biotin Nonisotopic Labeling Kit and associated protocols (Ambion; Applied Biosystems Inc.). Genomic DNA, isolated from cultured cells by using the Blood & Cell Culture DNA Midi Kit (Qiagen), was digested with KpnI/BamHI, followed by 0.7% agarose electrophoresis. After capillary transfer, the DNA on the positively charged nylon membrane (Ambion) was hybridized with the biotin-labeled probe in ULTRAhyb hybridization buffer (Ambion) at 42°C for 24 h. After several washes with SSC/0.1% SDS and 1ϫ wash buffer, membranes were treated with strep-alkaline phosphatase in blocking buffer for 15 min, washed with 1ϫ wash buffer, and treated with detection solution CDP-Star (BrightStar BioDetect Kit; Ambion), followed by exposure to a film.
RESULTS
Expression systems for regulation study
To study regulation of the SLC18A2 promoter, human cell lines that express endogenous SLC18A2 were searched among 5 human cell lines, including 4 DA cell lines [SH-SY5Y, IMR-32, SK-N-AS, and BE(2)-M17] and a non-neuronal cell line (HEK293T) by using qRT-PCR. As a result, SH-SY5Y expressed the highest levels of endogenous SLC18A2 mRNA and IMR-32 the second highest (Fig. 1A) . The data on BE(2)-M17 were Non-neuronal cell line HEK293T did not express detectable mRNA levels (nϭ3 each in duplicate). P ϭ 0.0006 overall, P Ͻ 0.001 for SH-SY5Y vs. others; ANOVA. B) PACAP38 regulation of haplotype A in circular vs. linearized pSLC18A2-6.3A-luc in SH-SY5Y (nϭ6 -12). *P Ͻ 0.05; Student's t test.
unreliable and are not shown here. We therefore used the human DA cell lines SH-SY5Y and IMR-32 as two systems for SLC18A2 regulation analysis that mimic different brain regions to some extent.
In this study we also chose linearized plasmid DNAs for expressional analyses. In an animal study, Miller and colleagues (21) had reported that PACAP38 upregulated VMAT2 levels in mouse striatum. However, PACAP38 failed to up-regulate SLC18A2 promoter activity when pSLC18A2-6.3A-luc (6.3-kb haplotype A in a Luc reporter vector; see Materials and Methods) was transiently expressed in SH-SY5Y. With the plasmid DNA linearized, PACAP38 was able to up-regulate the promoter activity (Fig. 1B) . These data suggested that the supercoiled structure of pSLC18A2-6.3A-luc affected regulation of the promoter activity. Therefore, regulation data from transient expression systems in this study were obtained with NheI-linearized DNAs.
Regulation of transient expression in SH-SY5Y and IMR-32
Seventeen agents (substances) were used in this regulation study, including 5 endogenous ones (listed in Table 1 ). All of the resultant regulation data are summarized in Table 2 (see Supplemental Material for details), and only those showing statistical significance based on t tests (in pairwise treatments) or by ANOVA posttest (Tukey's test) are described here.
Endogenous molecules
DA is an endogenous substrate of the VMAT2 protein and binds to DA receptors, inducing intracellular signaling that could regulate SLC18A2. In SH-SY5Y, treatment with 10 M DA for 18 h tended to up-regulate promoter activity of haplotype A by 1.55-fold (Pϭ0.058 by t tests), compared with the negative control (H 2 O Vc). DA had no effect on three other haplotypes in SH-SY5Y or IMR-32 (data not shown). Another four endogenous agents studied were PACAP38, Dyn, IGF-1, and TNF-␣, among which PACAP38 was the only one that up-regulated the promoter activity of A (2.03-fold) and C (2.02-fold) in SH-SY5Y and of A (1.46-fold), C (1.75-fold), and T (2.34-fold) in IMR-32, compared with the negative control.
Exogenous molecules, including AMPH, MK801, and forskolin
In SH-SY5Y/A (pSLC18A2-6.3A-luc) cells, MK801 upregulated A (2.06-fold), C (2.37-fold), and G (2.48-fold) but not T. Forskolin up-regulated the promoter activity of A by 2.02-fold but not the promoter activity of any other haplotypes in SH-SY5Y.
In IMR-32, haplotype dependence was less evident. Forskolin up-regulated promoter activity by the largest amount (2.80-fold) on G, second (1.84-fold) on A or 
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IMR-32 (
That is, AMPH did not affect any of these haplotypes in either of the two cell lines (Supplemental Fig. S3 ).
PKC, CaMKII, and phosphatase effectors: two PKC activators, PMA and PDD, the CaMK inhibitor KN-62, and the protein phosphatase inhibitor OA
In SH-SY5Y, PMA and PDD down-regulated the promoter activities of all 4 haplotypes, by ϳ0.6-fold for C, 0.5-fold for A, 0.4-fold for G, and 0.14-fold for T. OA up-regulated the A promoter activity (by 2.02-fold) but had no significant effect on 3 others; KN-62 had no effect on any of the haplotypes. In IMR-32, no significant effects were observed for any of the haplotypes (Supplemental Fig. S4 ).
Neurotoxins: MPP ϩ (a substrate of VMAT2) and 6-OHDA, the two most common toxins used in animal models for PD
In SH-SY5Y/A, MPP ϩ and 6-OHDA up-regulated the promoter activity by 1.62-and 2.24-fold. In SH-SY5Y/C, 6-OHDA displayed an up-regulation of 1.56-fold, and MPP ϩ up-regulation was not statistically significant. In SH-SY5Y/G, only MPP ϩ displayed a significant up-regulation (1.95-fold). In SH-SY5Y/T, 6-OHDA displayed a significant up-regulation (2.92-fold). In IMR-32/A, MPP ϩ down-regulated but 6-OHDA up-regulated the promoter activity by 0.75-and 1.39-fold. Neither of the toxins regulated C or G, and 6-OHDA also did not affect T in IMR-32 ( Supplemental Fig. S5) .
Regulation of endogenous expression in SH-SY5Y
Selected agents were examined for their effects on endogenous mRNA levels of SLC18A2 in SH-SY5Y by using qRT-PCR. DA was able to up-regulate SLC18A2 by 1.57-fold ( Fig. 2A) , a finding consistent with what was observed in the transient expression. TNF-␣ up-regulated the endogenous activity by 1.71-fold (Fig. 2B) . PMA had no effect (Fig. 2C) . The MAP kinase inhibitors LY294002 (PI3 kinase), U0126 (MEK1/2), and SB202190 (p38 kinase) down-regulated the endogenous activity by 0.61-, 0.80-, and 0.64-fold (Fig. 2D) . In the transient expression systems, the regulation data were generally unreliable because of vector effects, but haplotype dependence was observed for PI3 kinase inhibitor-mediated down-regulation in A (0.65-fold) vs. G (1.10-fold) in SH-SY5Y. No haplotype dependence was observed in IMR-32. Consistent with the transient expression, both MPP ϩ and 6-OHDA up-regulated the endogenous activity by 2.02-and 1.71-fold, compared with the negative controls (Fig.  2E) . These regulation data, except for PACAP38 and PMA, were all consistent with the findings from transient expression of haplotype A in SH-SY5Y. More consistently, SLC18A2 haplotyping of the SH-SY5Y genomic DNA confirmed that this cell line carried homozygous A. 
Regulation of stable expression
Chromatin structure may influence promoter regulation (22) , suggesting that expression from plasmid DNAs may or may not be able to reflect the chromosomal expression. To understand the potential discrepancy in the regulation of SLC18A2 between plasmids and chromosomes, stable cell lines were generated for haplotype A-luc hybrid to integrate into host chromosomes and to see whether the same regulations could be observed in the stable cell lines. Among 12 colonies obtained, one stable cell line, termed A7, expressed normal Luc activity (within 1-to 2-fold of the activity observed in transient expression) and was a pure cell line, based on immunocytochemical staining of Luc (Fig. 3A) . Regulation analyses showed that Dyn upregulated the promoter activity expressed in the host chromosome, whereas SB202190 again down-regulated the activity in this stable cell line (Fig. 3B) . Generally speaking, A7 displayed a regulation pattern similar to those observed in the transient or endogenous expression system. Southern blotting analyses of the genomic DNA digested with KpnI/BamHI showed that A7 carried a single copy of the hybrid and that this hybrid had Figure S1C ). SNPs at Ϫ106 and Ϫ103 were linked and analyzed together as AC in G, GA in A, and GC in C or T. Three nuclear proteins with differential binding activities are termed ␣, ␤, and ␦ here. Oligo specificity of these binding activities has been confirmed by competition experiments; the persistent band below the arrows was poly(A/T)-related activity.
been truncated by ϳ3 kb, probably at the 5Ј end (Fig.  3C) . The exact location of truncation has not been mapped yet, but A7 appeared to carry a 1-to 1.5-kb core promoter region upstream of the luc gene, and the observed regulations were executed by this core promoter.
Transcription factor (TF) binding to polymorphic sites in the core promoter
Because EMSA may faithfully reveal TF-promoter interactions that occur in vivo (23) (24) (25) , this method was used to investigate whether polymorphic sites in the core promoter region were bound by nuclear proteins. This core promoter region harbored 3 single-nucleotide polymorphisms (SNPs) at Ϫ106, Ϫ103, and Ϫ62 (3). To understand whether TFs could recognize these polymorphic sites, EMSA analyses were performed by using 35 S-labeled ds oligos (Supplemental Table S1C ) and nuclear proteins isolated from SH-SY5Y. As a result, there appeared to be 3 nuclear proteins that bound to these sites: ␣ bound to Ϫ106 to Ϫ103 G-A in haplotype A but not to other haplotypes; ␤ bound most to haplotype G, less to A, and not at all to C/T; and ␦ bound to the Ϫ62G allele that was carried by A, G, or T ( Fig. 3D; Supplemental Fig. S1C ). These differential binding activities were consistent with the haplotypedependent regulations observed in our transient expression systems.
DISCUSSION
Functional basis for haplotype selection
The critical finding in our analyses is that haplotype A, the highly selected one, is more regulatable than the infrequent haplotypes C, G, and T. A was regulated by 13 (76.5%) of the 17 agents tested, displaying the most responses relative to C (4 agents or 23.5%), G (3 agents  or 17 .6%), and T (2 agents or 11.8%) in SH-SY5Y. In particular, A was regulated by 4 of the 5 endogenous agents, compared with only 1 agent for C and none for G or T. These agents were relatively less active in IMR-32, probably because SLC18A2 is less active in this cell line, as IMR-32 expresses only 12% of the mRNA levels in SH-SY5Y (Fig. 1A) . The lesser activity suggests that fewer signaling pathways activate SLC18A2 in IMR-32. A was regulated by 4 (23.5%) agents, compared with C or T by 2 (11.8%) agents and G by 1 (5.9%) agent in IMR-32, a high A-regulatability pattern similar to that in SH-SY5Y (Table 2 ). These data on more regulations of A are consistent with the fact that A is recognized by more nuclear proteins than the other haplotypes (Fig. 3D) .
Interestingly, haplotype frequency is positively and almost linearly correlated with the number of significant regulations (Fig. 4) . Cladistic analysis of the four haplotypes shows a large distance between the two most frequent haplotypes, A and C. Evidently, A has been heavily favored during human biological history; T is relatively close to A but is deselected (Fig. 4A) . These data imply that high SLC18A2 regulatability is critical for survival during human evolution, which is consistent with variations in VMAT2 expression influencing brain integrity, function, and behaviors in knockout mice. In particular, the high regulatability may underlie forms of synaptic plasticity in which regulation of neurotransmission relies on variation in VMAT2-facilitated quantal size of transmitter release (26) . An intriguing question is the following: because low-activity haplotypes are associated with brain diseases, why did high-activity haplotypes such as C not have a greater survival advantage and were not highly selected (the frequency of C was 14.4% in the Caucasian populations)? Among other speculations (14, 27) , we may 14 .4% for C, 3.68% for G, and ϳ1% for T, based on 1460 Caucasian chromosomes combined from 2 independent studies (3, 4) . Haplotype T appeared to be a variant of haplotype H (3), due to a different simple sequence length polymorphism allele at Ϫ5199 and 2 different intron 1 alleles at ϩ321 and ϩ517 (Supplemental Figure S1C ; Table 3 in ref. 3), possibly representing a subgroup of the haplotype 1 that had a 2% frequency in Ͼ300 Caucasians (4). Because haplotypes G, H, K, and M together counted for 6% of the total haplotypes in 333 Caucasians (3), we estimate that this new haplotype, termed haplotype T, has a frequency of ϳ1%. The r 2 value indicates degree of linear fitness in cell type as noted; P indicates significance for the nonzero slope of linearity; letters indicate haplotypes.
postulate that C is much less regulatable, reducing the capacity for synaptic plasticity. It would be interesting to see whether SLC18A2 is associated with other monoamine-related features of human beings.
Dependence in SLC18A2 activity
The most consistent findings from this study are the haplotype dependence and the cell type-dependence in regulation of SLC18A2 promoter activity. Such haplotype dependence could range from 0.91-fold for G to 2.24-fold for A (a 2.5-fold difference) with 6-OHDA or from 0.14-fold for T to 0.48-fold for A (a 3.4-fold difference) with PMA in SH-SY5Y. Among the 17 agents investigated, 76.5% (13 agents) of them showed haplotype dependence in either of the DA cell lines (Table  2 ). Some agents regulated one haplotype but not another, including DA, Dyn, TNF-␣, forskolin, OA, and 6-OHDA. Others affected different haplotypes to various extents, including PMA and 6-OHDA in SH-SY5Y, forskolin in IMR-32, and PACAP38 in both cell lines. These haplotype-dependent regulations suggest that the 6.3-kb haplotypes are regulated by multiple signaling cascades, among which some may recognize TFs that bind to conserved elements or polymorphic sites in the core promoter.
The SLC18A2 regulatome: A-dominant
Several signaling cascades appear to contribute to the selection of A, based on the regulation data. These cascades are conjoined by five hubs including cAMP response element-binding protein (CREB) 1, ␤-arrestin 1, G-protein ␣ s , c-Raf-1, and ERK-1 (Fig. 5) and may make few points. Foremost, upstream of CREB1 is CaMKII that had been expected to activate CREB1, an activator of the VMAT2 gene (28) . However, this activation was not present in our expression systems because the CaMKII inhibitor KN-62 did not affect the promoter activity. Second, Ca 2ϩ appeared to play an Figure 5 . Signaling cascades that regulate A. Green asterisks, agents that regulated A (see Table 2 ); red boxes, major hubs each with Ն4 interactions; thick aquamarine lines, canonical pathways; thin green arrows, activation; thin red arrows, inhibition; thin gray arrows, unspecified; X, pathway that was not supported by the data from this study. Oxidative stress-related (MPP ϩ and 6-OHDA) pathways are not included. Bottom rectangle: schematic diagram of SLC18A2 regulated by TFs, including CREB1 and others (indicated by question mark) such as those indicated in Fig. 3D ; CRE (green), cAMP-responsive element; black arrows, unknown links between TFs and pathways. Pathways analysis was performed with MetaCore (36).
inhibitory role here because its reduced concentration seems to correlate with increased promoter activity, as suggested by data with PMA, PDD, MK801, and SB202190. This Ca 2ϩ -reverse correlation is further supported by the nicotine/nicotinic acetylcholine receptor (nAChR)-mediated down-regulation of A by 22% (Pϭ0.010, nϭ4; compared with the negative control), consistent with the finding that expression of a hypersensitive nAChR caused neurotoxicity and DA neuron death in mice (29) . Third, a single agent such as Dyn may regulate A via multiple pathways (bradykinin receptor B2, G-protein ␣ s , -type opioid receptor, the L-type Ca 2ϩ channel ␣1C subunit, and ␤-arrestin 1). Fourth, expression of an endogenous agent such as TNF-␣ can regulate as well as be regulated by related pathways (␤-arrestin 1, c-Jun pathway, and CREB1), implying the regulation of A by balancing of different related pathways. Finally, infrequent haplotypes are regulated by a limited number of pathways that involve CREB1 and Ca 2ϩ . Because agents that regulated the rare haplotypes all regulated the dominant A (Table 2) , these rare haplotypes may miss regulatory elements due to DNA sequence variation, which merits further investigation.
Technical caveats associated with reporter systems
Transient expression of the Luc-based reporter is used for transcriptional analyses by many biological fields (30 -34) , and data obtained by using such a reporter system could be spurious according to our observations. Foremost, regulation of the promoter on linearized plasmid DNA expressed transiently could result in data more similar to those obtained with endogenous, stable, or even in vivo expression than data obtained with circular plasmid DNA, based on the PACAP38 and DA data (35) (Figs. 1B; 2A, B; and 3B), suggesting that the regulations required an open DNA conformation (21) . The second observation was that kinase effectors could regulate mysterious promoters of the vector and such regulations of vector depended on the expression systems. These technical caveats associated with transient expression of reporter assays mandate data confirmation by a means different from transient expression.
CONCLUSIONS
Haplotype A is regulated by more pathways than the infrequent haplotypes C, G, and T, suggesting a positive correlation between haplotype frequency and number of regulators. TF-based further dissection of the haplotype-specific regulatory cascades can reveal specific mechanisms for haplotype selections. Haplotype-dependence can also be cell type-dependent and transgenic technology will help to clarify specific contributions of distinct SLC18A2 haplotypes to human evolution and diseases.
